BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20533251)

  • 1. [Perivascular innervation of the superior mesenteric artery: pathophysiological implications].
    Sastre E; Márquez-Rodas I; Blanco-Rivero J; Balfagón G
    Rev Neurol; 2010 Jun; 50(12):727-37. PubMed ID: 20533251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Martell M; Raurell I; Ezkurdia N; Cuenca S; Hernández-Losa J; Esteban R; Guardia J; Bosch J; Genescà J
    Liver Int; 2010 Apr; 30(4):593-602. PubMed ID: 19968782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension.
    Jurzik L; Froh M; Straub RH; Schölmerich J; Wiest R
    J Hepatol; 2005 Aug; 43(2):258-65. PubMed ID: 15963596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
    Heinemann A; Schuligoi R; Lippe IT; Stauber RE
    Pharmacology; 2009; 83(1):26-32. PubMed ID: 18987488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulation in vitro and in vivo in a rat model.
    Francque S; Wamutu S; Chatterjee S; Van Marck E; Herman A; Ramon A; Jung A; Vermeulen W; De Winter B; Pelckmans P; Michielsen P
    Liver Int; 2010 Mar; 30(3):365-75. PubMed ID: 19840249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension.
    Coll M; Genescà J; Raurell I; Rodríguez-Vilarrupla A; Mejías M; Otero T; Oria M; Esteban R; Guardia J; Bosch J; Martell M
    J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecules: mechanisms of arterial vasodilatation observed in the splanchnic and systemic circulation in portal hypertension.
    Iwakiri Y
    J Clin Gastroenterol; 2007; 41 Suppl 3():S288-94. PubMed ID: 17975478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of portal hypertension.
    Bosch J; Pizcueta P; Feu F; Fernández M; García-Pagán JC
    Gastroenterol Clin North Am; 1992 Mar; 21(1):1-14. PubMed ID: 1568769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrergic perivascular innervation in health and diseases: Focus on vascular tone regulation.
    Xavier FE
    Acta Physiol (Oxf); 2020 Sep; 230(1):e13484. PubMed ID: 32336027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of perivascular innervation in acetylcholine-induced endothelium-dependent vascular relaxation in the rat superior mesenteric arterial bed.
    Scott TM; Chafe L
    Artery; 1994; 21(1):51-62. PubMed ID: 7980031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension.
    Wu Y; Burns RC; Sitzmann JV
    Hepatology; 1993 Dec; 18(6):1416-21. PubMed ID: 8244267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
    Bernadich C; Bandi JC; Melin P; Bosch J
    Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic changes in splanchnic blood vessels in portal hypertension.
    Colle I; Geerts AM; Van Steenkiste C; Van Vlierberghe H
    Anat Rec (Hoboken); 2008 Jun; 291(6):699-713. PubMed ID: 18484617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local mechanisms of blood flow control by perivascular nerves and endothelium.
    Burnstock G
    J Hypertens Suppl; 1990 Dec; 8(7):S95-106. PubMed ID: 1982771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    La Villa G; Barletta G; Pantaleo P; Del Bene R; Vizzutti F; Vecchiarino S; Masini E; Perfetto F; Tarquini R; Gentilini P; Laffi G
    Hepatology; 2001 Jul; 34(1):19-27. PubMed ID: 11431729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated hemodynamic changes controlled by splanchnic nerve.
    Sato MA; Morrison SF; Lopes OU; Colombari E
    Auton Neurosci; 2006 Jun; 126-127():202-10. PubMed ID: 16567132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between vascular reactivity in vitro and blood flows in rats with cirrhosis.
    Pateron D; Oberti F; Lefilliatre P; Veal N; Tazi KA; Sogni P; Poirel O; Heller J; Moreau R; Cales P; Lebrec D
    Clin Sci (Lond); 1999 Sep; 97(3):313-8. PubMed ID: 10464056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of central and peripheral histamine H(3) receptors in the control of the vascular tone and oxygen uptake in the mesenteric circulation of the rat.
    Obuchowicz R; Pawlik MW; Brzozowski T; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):255-67. PubMed ID: 15082882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of nitric oxide synthase blockers on mesenteric blood flow with bile duct ligation.
    Yuksel BC; Tanriverdi P; Ozel H; Avsar FM; Topaloglu S; Iskit AB
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxix-ccxxi. PubMed ID: 15244184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.